OC
ATHN

Oppenheimer & Co’s Athenahealth, Inc. ATHN Stock Holding History

Oppenheimer & Co’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,345
Closed -$447K – 1409
2018
Q3 		$447K Buy
3,345
+316
+10% +$47.3K 0.01% 906
2018
Q2 		$482K Buy
3,029
+826
+37% +$122K 0.01% 877
2018
Q1 		$315K Buy
+2,203
New +$301K 0.01% 1036

Other funds holding ATHN

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Oppenheimer & Co's ATHN Position: Q4 2018 in Review

Oppenheimer & Co sold out of Athenahealth, Inc. (ATHN) in Q4 2018, closing a stake of 3,345 shares — an estimated $447K sold.

Oppenheimer & Co first reported a position in ATHN in Q1 2018 and held it in 3 quarters. The position peaked at $482K in Q2 2018. 263 funds tracked by Wall St. Rank hold ATHN as of Q4 2018.

  • Oppenheimer & Co reported no remaining Athenahealth, Inc. position as of Q4 2018 after selling out during the quarter.
  • Oppenheimer & Co sold 3,345 Athenahealth, Inc. shares in Q4 2018, an estimated $447K.
  • Oppenheimer & Co first reported a position in Athenahealth, Inc. in Q1 2018 and held it in 3 quarters.
  • Oppenheimer & Co's Athenahealth, Inc. position peaked at $482K in Q2 2018.
  • 263 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q4 2018.

Based on Oppenheimer & Co's 13F filing for Q4 2018, filed 29 Jan 2019.